Oral Glucose Tolerance Test

Cross-source consensus on Oral Glucose Tolerance Test from 1 sources and 5 claims.

1 sources · 5 claims

Uses

OGTT data will be mathematically modelled to calculate insulin sensitivity, insulin secretion, pancreatic beta-cell function, and insulin clearance. — Protocol for a prospective cohort study for the assessment of sarcopenia in gestational diabetes: the SiGnal-D study
High-risk women undergo an early OGTT at weeks 16 to 18 of gestation, while standard screening occurs at weeks 24 to 28. — Protocol for a prospective cohort study for the assessment of sarcopenia in gestational diabetes: the SiGnal-D study
Blood is collected at four time points (0, 30, 60, and 120 minutes after glucose ingestion) to measure plasma glucose, insulin, and C-peptide. — Protocol for a prospective cohort study for the assessment of sarcopenia in gestational diabetes: the SiGnal-D study
OGTT-based insulin sensitivity indices are surrogates for the euglycaemic clamp, which is the reference method but too burdensome for routine clinical use. — Protocol for a prospective cohort study for the assessment of sarcopenia in gestational diabetes: the SiGnal-D study
Because sarcopenia combined with GDM may represent a peculiar metabolic condition, some standard insulin sensitivity indices may be unreliable in this population. — Protocol for a prospective cohort study for the assessment of sarcopenia in gestational diabetes: the SiGnal-D study